Grant of €1.2M awarded to project researching cure for chronic bone pain
Netris Pharma’s lead product was awarded €1.2 million Eurostar grant to make an antibody therapeutic to treat arthritis and metastatic bone cancer pain.
Netris Pharma’s lead product was awarded €1.2 million Eurostar grant to make an antibody therapeutic to treat arthritis and metastatic bone cancer pain.
Novotech adds EastHorn, a European CRO, to its global network, after having worked together for a number of years.